Recombinant multi-species NFS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NFS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Iron-sulfur clusters are required for the function of many cellular enzymes. The proteins encoded by this gene supply inorganic sulfur to these clusters by removing the sulfur from cysteine, creating alanine in the process. This gene uses alternate in-frame translation initiation sites to generate mitochondrial forms and cytoplasmic/nuclear forms. Selection of the alternative initiation sites is determined by the cytosolic pH. The encoded proteins belong to the class-V family of pyridoxal phosphate-dependent aminotransferases. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2010]
The Alternative Names of target: COXPD52,Cysteine desulfurase,HUSSY-08,IscS,NFS1,NIFS,Nfs1,Nifs,m-Nfs1,m-Nfsl
Go
to NFS1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13438-Ag-1/ GM-Tg-hg-IP13438-Ag-2 | Human NFS1 protein | Human |
| GM-Tg-rg-IP13438-Ag-1/ GM-Tg-rg-IP13438-Ag-2 | Rat NFS1 protein | Rat |
| GM-Tg-mg-IP13438-Ag-1/ GM-Tg-mg-IP13438-Ag-2 | Mouse NFS1 protein | Mouse |
| GM-Tg-cynog-IP13438-Ag-1/ GM-Tg-cynog-IP13438-Ag-2 | Cynomolgus/Rhesus macaque NFS1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13438-Ag-1/ GM-Tg-felg-IP13438-Ag-2 | Feline NFS1 protein | Feline |
| GM-Tg-cang-IP13438-Ag-1/ GM-Tg-cang-IP13438-Ag-2 | Canine NFS1 protein | Canine |
| GM-Tg-bovg-IP13438-Ag-1/ GM-Tg-bovg-IP13438-Ag-2 | Bovine NFS1 protein | Bovine |
| GM-Tg-equg-IP13438-Ag-1/ GM-Tg-equg-IP13438-Ag-2 | Equine NFS1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13438-Ag-1/ GM-Tg-hg-IP13438-Ag-2;
GM-Tg-rg-IP13438-Ag-1/ GM-Tg-rg-IP13438-Ag-2;
GM-Tg-mg-IP13438-Ag-1/ GM-Tg-mg-IP13438-Ag-2; GM-Tg-cynog-IP13438-Ag-1/ GM-Tg-cynog-IP13438-Ag-2; GM-Tg-felg-IP13438-Ag-1/ GM-Tg-felg-IP13438-Ag-2; GM-Tg-cang-IP13438-Ag-1/ GM-Tg-cang-IP13438-Ag-2; GM-Tg-bovg-IP13438-Ag-1/ GM-Tg-bovg-IP13438-Ag-2; GM-Tg-equg-IP13438-Ag-1/ GM-Tg-equg-IP13438-Ag-2 |
| Products Name | NFS1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NFS1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NFS1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.